Interleukin-1 beta modulation of norepinephrine release from rat myenteric nerves

Area of Science:

• Neuroimmunology
• Gastrointestinal Physiology

Background:

• Interleukin-1 beta (IL-1 beta) is a key inflammatory cytokine.
• The myenteric plexus regulates gastrointestinal motility and neurotransmission.

Purpose of the Study:

• To investigate the effect of human recombinant IL-1 beta on norepinephrine release in the rat myenteric plexus.
• To elucidate the mechanisms underlying IL-1 beta's influence on neurotransmitter release.

Main Methods:

• Isolated longitudinal muscle-myenteric plexus from rat intestine.
• Stimulation of [3H]norepinephrine ([3H]NE) release using KCl and electrical field stimulation.
• Assessment of IL-1 beta's effects on basal and evoked [3H]NE release over time.
• Investigation of cycloheximide's role in protein synthesis inhibition.
• Use of anti-IL-1 beta antibody and IL-1 receptor antagonist for mechanism validation.

Main Results:

• IL-1 beta induced a biphasic, time-dependent suppression of evoked [3H]NE release.
• An initial suppression (30 min) was cycloheximide-independent.
• A delayed peak suppression (120 min) was cycloheximide-sensitive, indicating protein synthesis involvement.
• IL-1 beta also stimulated cycloheximide-sensitive [35S]methionine uptake.
• The effects were dose-dependent (maximal at 10 ng/ml) and blocked by IL-1 neutralizing agents.

Conclusions:

• IL-1 beta suppresses norepinephrine release from the rat myenteric plexus via two distinct mechanisms.
• One mechanism is rapid and independent of protein synthesis.
• The second mechanism is delayed and mediated by protein synthesis, potentially involving endogenous IL-1 signaling.